Search for: "Merck and Co," Results 321 - 340 of 1,277
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jan 2014, 4:59 am by Robert Kreisman
A settlement agreement that includes claims of more than 1,200 plaintiffs in federal and state courts has been reached with Merck & Co. [read post]
15 Jan 2014, 5:12 pm
Meantime, the drug’s manufacturer, Merck & Co., has agreed to a proposed $27.7 million to settle ONJ lawsuits filed by plaintiffs who say that the bisphosphonate caused their jaws to deteriorate. [read post]
29 Dec 2013, 12:31 pm by Ron Coleman
For three years — from October 2006 through December 2009 — while I was a partner at Jones Day, I co-hosted the Drug and Device Law Blog with Jim Beck, of Dechert. [read post]
24 Dec 2013, 5:32 am by Lawrence B. Ebert
In re Merck & Co., Inc. 800 F.2d 1091, 1097 (Fed. [read post]
19 Dec 2013, 4:56 pm
(Enlarged Board of Appeal in G2/98).Priority can be lost by:narrowing down the disclosure from the priority document in a manner which the invention could not be derived directly and unambiguously from it (Pharmacia Corp v Merck & Co Inc [2002] RPC 41); orwidening or generalizing from the priority disclosure (Beloit Technologies Inc and another v Valmet Paper Machinery Inc and another [1995] RPC 7005 and Unilin)The story continues in Part II. [read post]
12 Dec 2013, 7:20 am by Jon Gelman
Today's post was shared by FairWarning and comes from www.reuters.com By Nate Raymond and Jessica DyeNEW YORK Dec 9 (Reuters) - Merck & Co Inc said on Monday that it was prepared to pay $27.7 million to settle lawsuits by hundreds of people who sued the company over allegations that its osteoporosis drug Fosamax caused bones in the jaw to deteriorate.Lawyers for Merck and plaintiffs disclosed the proposed settlement at a court hearing in New York to resolve 1,140… [read post]
21 Oct 2013, 1:57 pm
Merck & Co., 948 A.2d 587, 595 (N.J. 2008) (citations omitted).14  Bailey v. [read post]
21 Oct 2013, 11:43 am by Ronald V. Miller, Jr.
 The FDA examined and confirmed the problem in 2011; however, Merck & Co., manufacture of NuvaRing, failed to warn users of the increased risks in any of their advertisements. [read post]
16 Oct 2013, 5:55 am by Lawrence B. Ebert
See In re Merck & Co., Inc., 800 F.2d 1091,1097 (Fed. [read post]
15 Oct 2013, 10:03 pm by Stéphane Horel
He also co-authored a 2010 article on degradation products of pesticides with an employee from chemical and pesticide manufacturer BASF and a private consultant and two studies on 3-(4-methylbenzylidene)camphor, a UV filter, with employees from this chemical’s manufacturer, Merck, in 2006. [read post]
19 Sep 2013, 9:53 am by Bexis
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
10 Sep 2013, 4:00 am by Alan Macek
In a decision released in July, Merck & Co., Inc. v. [read post]
21 Aug 2013, 5:12 am by Lawrence B. Ebert
One cannot show nonobviousness by attacking referencesindividually where the rejections are based on combinations of references.In re Merck & Co., 800 F.2d 1091, 1097(Fed. [read post]
4 Aug 2013, 5:30 am by Barry Sookman
http://t.co/qDmsnfGJFq -> Google reveals avalanche of link removal requests http://t.co/lWd2K4FgRa -> USPTO Again Rejects Apple’s Claim of Pinch-to-Zoom Patent http://t.co/YrME6CTcOi -> Four Tips from Merck’s $180M Patent Damages Win Against Apotex http://t.co/znvGmK3isO -> Google scholar link to FOX BROADCASTING COMPANY, INC. v. [read post]